Aberrant staining for p16INK4a was found in 71.88% (23/32) of ERα negative cases out of a total of 92 cases of invasive carcinoma, compared to ERα positive tumors (6.67%, 4/60). Here, CDKN2A is linked to invasive carcinoma.